Cytovene and Neupogen drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cytovene (ganciclovir) and Neupogen (filgrastim). Common drug interactions include cytokine release syndrome among females and blood creatinine increased among males.

The phase IV clinical study analyzes what interactions people have when they take Cytovene and Neupogen. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Cytovene?

Cytovene has active ingredients of ganciclovir. eHealthMe is studying from 419 Cytovene users. Check the latest studies of Cytovene.

What is Neupogen?

Neupogen has active ingredients of filgrastim. It is often used in agranulocytosis. eHealthMe is studying from 23,898 Neupogen users. Check the latest studies of Neupogen.



On Aug, 10, 2026

19 people who take Cytovene and Neupogen together, and have interactions are studied.

Cytovene and Neupogen drug interactions.

What are the common drug interactions of Cytovene and Neupogen, by gender? *:

female:

  1. Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
  2. Klebsiella infection
  3. Abdominal abscess (collection of pus in abdomen)
  4. Hypotension (abnormally low blood pressure)
  5. Rash
  6. Urinary tract infection

male:

  1. Blood creatinine increased
  2. Lung infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung)
  3. Headache (pain in head)
  4. Jaundice cholestatic
  5. Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
  6. Mouth ulceration (mouth ulcers)
  7. Pancreatitis acute (sudden inflammation of pancreas)
  8. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  9. Pneumonia
  10. Testis cancer (exc germ cell) (non germ cell cancer of testes)

What are the common drug interactions of Cytovene and Neupogen, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Convulsions (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled of muscles contract and relax rapidly and repeatedly)
  2. Febrile convulsion (a convulsion associated with a significant rise in body temperature)
  3. Headache (pain in head)
  4. Hypertension (high blood pressure)
  5. Hypertensive encephalopathy (neurological dysfunction induced by malignant hypertension)
  6. Pyrexia (fever)

10-19:

n/a

20-29:

n/a

30-39:

  1. Blood carbon dioxide decreased
  2. Blood creatinine increased
  3. Haematoma (collection of blood outside the blood vessels)
  4. Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
  5. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  6. Pneumonia
  7. Testis cancer (exc germ cell) (non germ cell cancer of testes)
  8. Urinary tract infection
  9. Weakness
  10. Abscess (pus)

40-49:

  1. Renal failure (kidney dysfunction)
  2. White blood cell count increased
  3. Blood bilirubin increased
  4. Jaundice cholestatic
  5. Mouth ulceration (mouth ulcers)
  6. Pancreatitis acute (sudden inflammation of pancreas)
  7. Pyrexia (fever)
  8. Deafness
  9. Lung disorder (lung disease)
  10. Blood creatinine increased

50-59:

  1. Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
  2. Klebsiella infection
  3. Hypotension (abnormally low blood pressure)
  4. Urinary tract infection

60+:

  1. Abdominal abscess (collection of pus in abdomen)
  2. Rash

What are the existing conditions these people have? *

  1. Agitation (state of anxiety or nervous excitement): 1 person, 5.26%
  2. Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Cytovene and Neupogen?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Cytovene and Neupogen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cytovene:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Neupogen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cytovene and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Neupogen and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ganciclovir and filgrastim (the active ingredients of Cytovene and Neupogen, respectively), and Cytovene and Neupogen (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: